1Rosengren A, Wilhelmsen L, Eriksson E, et al. Lipeprotein(a) and coronary heart disease: a prospective case-control study in a general population sample of middle aged men. BMJ, 1990, 301 : 1248-1251.
2Budde T, Fechtrup C, Bosenberg E, et al. Plasma Lp (a) levels correlate with number, severity, and length-extension of coronary lesions in male patients undergoing coronary artefiography for clinically suspected coronary atherosclerosis. Arteriescler Thromb,1994, 14: 1730-1736.
3Sirikci O, Aytekin V, Demiroglu IC et al. Association of lipoprotein(a) concentration and apo (a) isoform size with restenosis after percutaneous transluminal coronary angloplasty. Int J Clin Lab Res,2000, 30:93-99.
4Miyata M, Biro S, Arima S, et al. High serum concentration of lipoprotein (a) is a risk factor for restenosis after percutaneous transluminal coronary angioplasty in Japanese patients with singlevessel disease. Am Heart J, 1996, 132 (2 Pt 1) :269-273.
5David J, Richard A, Rober S, et al. Relation of plasma lipoprotein(a) to infarct artery patency in survivors of myocardial infarction.Circulation, 1993, 88: 935-940.
6Igarashi Y, Yamaura M, Ito M, et al. Elevated serum lipoprotein(a) is a risk factor for left atrial thrombus in patients with chronic atrial fibrillation: A transesophageal echocardiographic study. Am Heart J, 1998 , 136: 965-971.
7Igarashi Y, Kasal H, Yamashita F, et al. Lipoprotein ( a), left atrial appendage function and thromboembolic risk in patients with chronic nonvalvular atrial fibrillation. Jpn Circ J, 2000, 64:93-98.
8Wolf PA. Abbott RD, Kannel WB. Atrial fibrillation: a major contributor to stroke in the elderly: The Framingham Study. Arch Intern Med, 1987, 147: 1561-1564.
